Immediate Impact
3 from Science/Nature 60 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of I. A. Small being referenced
Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer
2014
Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| I. A. Small | 611 | 430 | 165 | 214 | 48 | 948 | |
| L. Cerezo | 406 | 507 | 374 | 201 | 53 | 1.2k | |
| Ben G. Szabó | 230 | 242 | 242 | 144 | 33 | 742 | |
| Carlo Gobitti | 495 | 362 | 260 | 156 | 54 | 970 | |
| Rosa M. Dávila | 249 | 252 | 292 | 87 | 42 | 1.0k | |
| Eugenio Borsatti | 466 | 259 | 145 | 350 | 34 | 919 | |
| J.M. Cosset | 256 | 239 | 119 | 207 | 42 | 786 | |
| Vicharn Lorvidhaya | 247 | 364 | 462 | 145 | 46 | 1.2k | |
| A. Lusinchi | 498 | 363 | 486 | 166 | 47 | 1.0k | |
| Sheung-Fat Ko | 300 | 206 | 453 | 203 | 44 | 938 | |
| S. Bourdin | 422 | 315 | 254 | 193 | 39 | 859 |
All Works
Login with ORCID to disown or claim papers
Loading papers...